Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus

OrthoCarolina Research Institute, Inc.60 enrolled

Overview

The purpose of this study is to determine whether patients undergoing a dorsal cheilectomy procedure with implementation of amniotic membrane tissue results in improved clinical and functional outcomes compared to a standard dorsal cheilectomy procedure. Specific Aim 1: To compare American Orthopedic Foot and Ankle Society (AOFAS) scores between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 1: Clinical and functional outcomes, as measured by the AOFAS , in the patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior to those without. Specific Aim 2: To compare range of motion between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 2: Patient to undergo dorsal cheilectomy and implantation of amniotic membrane tissue will demonstrate less postoperative stiffness as measured from the pre-and postoperative radiographs. Specific Aim 3: To compare Foot Function Index (FFI) scores between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 3: Clinical and functional outcomes, as measured by the FFI, the patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior to those without.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Hallux Rigidus

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients presented with an isolated diagnosis of type II hallux rigidus who are candidates for operative management with dorsal cheilectomy. * Patients over the age of 18 able to consent to participate * The subject is psychosocially, mentally, and physically able to understand and comply with the requirements of the study Exclusion Criteria: * \< 18 years of age * Patients that use ambulatory assistive devices * Patients with systemic inflammtory arthritis * Patient undergoing revision surgery for hallux rigidus to the ipsilateral extremity * Patients with significant arthritis requiring alternative surgery other than dorsal cheilectomy

Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes